TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17998493

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole, 1 double-strength tablet twice daily for 3 days
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Nitrofurantoin, 100 mg twice daily for 5 days
Number of subjects: 338

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (nonsusceptible isolate)
Number of subjects: 338
Study: 15738432

Group type: EXPERIMENTAL
Intervention: Formal test of capacity followed by request for consent or assent from a proxy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined informal capacity/consent process
Number of subjects: 0
Study: 12202434

Group type: EXPERIMENTAL
Intervention: 6-step thawing method
Number of subjects: 293

Group type: COMPARATOR
Intervention: 2-step thawing method
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Overall clinical pregnancies from thawed blastocysts
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Overall live births from thawed blastocysts
Number of subjects: 293
Study: 9659676

Group type: EXPERIMENTAL
Intervention: Supervised training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Self-monitored training
Number of subjects: 100
Study: 7510911

Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg
Number of subjects: 0
Study: 2508287

Group type: EXPERIMENTAL
Intervention: Transcutaneous nitroglycerin patches
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 26
Study: 1102557

Group type: EXPERIMENTAL
Intervention: Velvet pad rinse technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Velvet pad imprint method
Number of subjects: 0
Study: 31042420

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 581

Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 581

Group type: COMPARATOR
Intervention: CMS classification
Number of subjects: 581
Study: 29716843

Group type: EXPERIMENTAL
Intervention: Active taVNS (tragus stimulation) with parameters 500μs 10 Hz
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Active taVNS (tragus stimulation) with parameters 500μs 25 Hz
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Active taVNS (tragus stimulation)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (earlobe stimulation)
Number of subjects: 35
Study: 27049323

Group type: EXPERIMENTAL
Intervention: Dapoxetine 60 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dapoxetine 30 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 120
Study: 25277335

Group type: EXPERIMENTAL
Intervention: MGuard embolic protection stent
Number of subjects: 431

Group type: COMPARATOR
Intervention: Standard metallic stents
Number of subjects: 431
Study: 21429719

Group type: EXPERIMENTAL
Intervention: n-3 long chain polyunsaturated fatty acids (3.7 g/d providing 1.7 g/d EPA and 1.2 g/d DHA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fenofibrate (200 mg/d)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 21151623

Group type: EXPERIMENTAL
Intervention: Tramadol SR 200 mg tablet (test product)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference product (tramadol SR 200 mg tablet)
Number of subjects: 0
Study: 18154655

Group type: EXPERIMENTAL
Intervention: Artesunate + sulphadoxine-pyrimethamine
Number of subjects: 218

Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 218

Group type: COMPARATOR
Intervention: Sulphadoxine-pyrimethamine alone
Number of subjects: 218
Study: 15756485

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention including educational and organizational components, technical devices to reduce fall-related injuries
Number of subjects: 200

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention
Number of subjects: 200
Study: 12411225

Group type: EXPERIMENTAL
Intervention: Atomoxetine (once daily for 6 weeks)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo (once daily for 6 weeks)
Number of subjects: 171
Study: 9708652

Group type: EXPERIMENTAL
Intervention: Nonrestenotic PTCA
Number of subjects: 890
Study: 7898297

Group type: EXPERIMENTAL
Intervention: Neutrally-framed information about chemotherapeutic treatment
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Positively-framed information about chemotherapeutic treatment
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Negatively-framed information about chemotherapeutic treatment
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Education
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Trial entry preferences
Number of subjects: 90
Study: 2651329

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 6
Study: 212171

Group type: EXPERIMENTAL
Intervention: Whole brain irradiation (2000 rad in 2 weeks)
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Short course local irradiation (4200 rad in 3 weeks)
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Prophylactic brain irradiation (low doses)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Intermediate course irradiation (5000 rad in 5 weeks)
Number of subjects: 341
Study: 28810442

Group type: EXPERIMENTAL
Intervention: Internet‐administered cognitive behavioral treatment
Number of subjects: 54

Group type: COMPARATOR
Intervention: Health education (control)
Number of subjects: 54
Study: 28665989

Group type: EXPERIMENTAL
Intervention: Active tDCS + exercise (AT+EX)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham tDCS + exercise (ST+EX)
Number of subjects: 30
Study: 25106547

Group type: EXPERIMENTAL
Intervention: Thyme honey nasal spray
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 23246640

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (400-4800 IU/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0
Study: 21291438

Group type: EXPERIMENTAL
Intervention: Family Check‐Up (FCU) intervention
Number of subjects: 593

Group type: COMPARATOR
Intervention: Control group (middle school services as usual)
Number of subjects: 593
Study: 19473635

Group type: EXPERIMENTAL
Intervention: Oral falecalcitriol
Number of subjects: 21

Group type: COMPARATOR
Intervention: Intravenous calcitriol
Number of subjects: 21
Study: 19088604

Group type: EXPERIMENTAL
Intervention: Simulation education sessions using a manikin with low-fidelity capabilities
Number of subjects: 74

Group type: COMPARATOR
Intervention: Self-directed learning package (SDLP) only
Number of subjects: 74

Group type: COMPARATOR
Intervention: SDLP plus two scenario-based PowerPoint workshops
Number of subjects: 74
Study: 15209198

Group type: EXPERIMENTAL
Intervention: Saline flush during vasectomy (10 mL normal saline)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (no saline flush)
Number of subjects: 106
Study: 12452382

Group type: EXPERIMENTAL
Intervention: Rectal distension inducing an urgency for defecation (average volume of air: 72.5 ml)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control session (20 ml of air in rectal balloon)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Rectal distension inducing an urgency for defecation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Both sessions (rectal distension and control)
Number of subjects: 14
Study: 9690724

Group type: EXPERIMENTAL
Intervention: Omeprazole (5-day administration)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no omeprazole)
Number of subjects: 14
Study: 8015747

Group type: EXPERIMENTAL
Intervention: Vitamin and mineral supplementation (beta-carotene, vitamin E, selenium)
Number of subjects: 0
Study: 2732142

Group type: EXPERIMENTAL
Intervention: FCE 22101 (1 g dose, intravenous bolus) after 750 ml water (treatment A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: FCE 22101 (1 g dose, intravenous bolus) after 8 h of water restriction (treatment B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo under water restriction (treatment C)
Number of subjects: 60
Study: 4606370

Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gold
Number of subjects: 0
Study: 31600590

Group type: EXPERIMENTAL
Intervention: Maternal depression
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Maternal baseline depression
Number of subjects: 206

Group type: COMPARATOR
Intervention: Non-depressed comparison mothers
Number of subjects: 206
Study: 31733755

Group type: EXPERIMENTAL
Intervention: Comedy video (mirthful laughter)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Documentary video (control)
Number of subjects: 40
Study: 27209586

Group type: EXPERIMENTAL
Intervention: CHF 5993 with cimetidine (800 mg twice daily for 6 days)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: CHF 5993 with cimetidine
Number of subjects: 26

Group type: COMPARATOR
Intervention: CHF 5993 alone
Number of subjects: 26
Study: 25998033

Group type: EXPERIMENTAL
Intervention: Standard oxygen therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: No supplemental oxygen
Number of subjects: 100
Study: 23857809

Group type: EXPERIMENTAL
Intervention: Computerized cognitive rehabilitation (Cog‐trainer) plus usual rehabilitation (UR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual rehabilitation (UR)
Number of subjects: 60
Study: 21723220

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19735529

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16293673

Group type: EXPERIMENTAL
Intervention: Intention to resume smoking (IRS)
Number of subjects: 301

Group type: COMPARATOR
Intervention: No intention to resume smoking (no IRS)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Number of months currently abstinent
Number of subjects: 301
Study: 15321433

Group type: EXPERIMENTAL
Intervention: VT x 3 min
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 8 DB
Number of subjects: 20

Group type: COMPARATOR
Intervention: 4 DB
Number of subjects: 20
Study: 11766956

Group type: EXPERIMENTAL
Intervention: Home physiotherapy program, 3 times a week for 6 weeks
Number of subjects: 33
Study: 9028089

Group type: EXPERIMENTAL
Intervention: Amrinone (3-5 mg.kg-1.min-1) combined with dopamine (3-5 mg.kg-1.min-1)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Nitroglycerin (0.3-1.0 mg.kg-1.min-1) combined with dopamine (3-5 mg.kg-1.min-1)
Number of subjects: 9
Study: 8500234

Group type: EXPERIMENTAL
Intervention: Optimal therapy in patients < 75 years old
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 1000
Study: 2952156

Group type: EXPERIMENTAL
Intervention: Topical clindamycin phosphate 1%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral tetracycline
Number of subjects: 60
Study: 29110281

Group type: EXPERIMENTAL
Intervention: weight-loss intervention + 50,000 IU/week oral vitamin D3
Number of subjects: 60

Group type: COMPARATOR
Intervention: weight-loss intervention + placebo
Number of subjects: 60
Study: 27930479

Group type: EXPERIMENTAL
Intervention: Career management intervention
Number of subjects: 684

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 684
Study: 24703512

Group type: EXPERIMENTAL
Intervention: Myofascial release (MFR)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sham ultrasound therapy (SUST)
Number of subjects: 66
Study: 23677313

Group type: EXPERIMENTAL
Intervention: Burch urethropexy
Number of subjects: 233

Group type: COMPARATOR
Intervention: No urethropexy
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 233
Study: 19865092

Group type: EXPERIMENTAL
Intervention: 40 mg atorvastatin daily for 12 weeks
Number of subjects: 131

Group type: COMPARATOR
Intervention: Matching placebo for 12 weeks
Number of subjects: 131
Study: 18262390

Group type: EXPERIMENTAL
Intervention: High-fat test meal (59 +/- 4 g fat; 71% of energy as fat) with high saturated:unsaturated fatty acids ratio (approximately 71:29)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-fat test meal (59 +/- 4 g fat; 71% of energy as fat) with low saturated:unsaturated fatty acids ratio (approximately 55:45)
Number of subjects: 18
Study: 16169354

Group type: EXPERIMENTAL
Intervention: Aspirin-sensitive patients
Number of subjects: 117

Group type: COMPARATOR
Intervention: Aspirin-resistant patients
Number of subjects: 117
Study: 12663284

Group type: EXPERIMENTAL
Intervention: L-amino acid diet supplying either 14 and 30 mg leucine x kg(‐1)x d(‐1) or 22 and 40 mg leucine x kg(‐1)x d(‐1)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Habitual cereal-and-lentil-based diets
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: [2H3]leucine administered orally at an intake of 40 mg x kg(‐1) x d(‐1)
Number of subjects: 26
Study: 10638903

Group type: EXPERIMENTAL
Intervention: Vecuronium infusion at 5 microg x kg(‐1) x min(‐1) until the first response of each train‐of‐four had decreased by 70%.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Vecuronium infusion at 20 microg x kg(‐1) x min(‐1) for 10 min.
Number of subjects: 12
Study: 8799921

Group type: EXPERIMENTAL
Intervention: Laparoscopic cyst excision
Number of subjects: 131

Group type: COMPARATOR
Intervention: Laparoscopic cyst aspiration
Number of subjects: 131
Study: 1320538

Group type: EXPERIMENTAL
Intervention: High-voltage pulsed galvanic stimulation at 2 pulses/s
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-voltage pulsed galvanic stimulation at 128 pulses/s
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Isometric contraction of calf muscles
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-voltage pulsed galvanic stimulation at 32 pulses/s
Number of subjects: 12
Study: 6529613

Group type: EXPERIMENTAL
Intervention: 5 mg xipamide
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 10 mg xipamide
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 20 mg xipamide
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 30449747

Group type: EXPERIMENTAL
Intervention: Intervention interns (home visitation)
Number of subjects: 52
Study: 26501497

Group type: EXPERIMENTAL
Intervention: Relationship education intervention
Number of subjects: 1034

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 1034
Study: 24387700

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 84

Group type: COMPARATOR
Intervention: Active Control (nonaerobic exercise)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Yoga vs Active Control
Number of subjects: 84
Study: 22561416

Group type: EXPERIMENTAL
Intervention: Sauna-only sessions (S)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercise followed by sauna sessions (ES)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control resting session
Number of subjects: 10
Study: 20337866

Group type: EXPERIMENTAL
Intervention: 16 mL tea
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 25 mL tea
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 20 mL tea
Number of subjects: 12
Study: 18420395

Group type: EXPERIMENTAL
Intervention: Lean fish (3 x 150 g portions of cod/week)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Fatty fish (3 x 150 g portions of salmon/week)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Fish oil (DHA+EPA capsules, no seafood)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Control (sunflower oil capsules, no seafood)
Number of subjects: 275
Study: 16110022

Group type: EXPERIMENTAL
Intervention: TP53 mutation
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: MSI-H
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: KRAS mutations
Number of subjects: 391
Study: 12852722

Group type: EXPERIMENTAL
Intervention: Strict fasting capillary glucose target level (< 6.5 mmol/l)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Less strict fasting capillary glucose target level (< 8.5 mmol/l)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Overall group (no specific intervention)
Number of subjects: 214
Study: 10681104

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: COMPARATOR
Intervention: Comparison group (non-volunteers)
Number of subjects: 63
Study: 8596231

Group type: EXPERIMENTAL
Intervention: Trained service dogs (received 1 month after the study began)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Wait-list control group (received service dogs in month 13 of the study)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Trained service dogs
Number of subjects: 48
Study: 2015447

Group type: EXPERIMENTAL
Intervention: Day care treatment
Number of subjects: 92

Group type: COMPARATOR
Intervention: Out-patient care
Number of subjects: 92
Study: 6781618

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Immunotherapy
Number of subjects: 82

Group type: COMPARATOR
Intervention: Initial platelet counts
Number of subjects: 82

Group type: COMPARATOR
Intervention: Age
Number of subjects: 82

Group type: COMPARATOR
Intervention: Total white cell count
Number of subjects: 82

Group type: COMPARATOR
Intervention: Granulocyte counts
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Relapse rates
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Survival after five years
Number of subjects: 82
Study: 31194759

Group type: EXPERIMENTAL
Intervention: %HRR-CV during cardiovascular training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: %HRR-AR during active recovery phases
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison of %HRR-CV with 40% HRR threshold
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison of %HRR-AR and %HRR-CV
Number of subjects: 30
Study: 28412163

Group type: EXPERIMENTAL
Intervention: Tail docking using clippers in 2-day-old pigs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tail docking using clippers in 20-day-old pigs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tail docking using cautery iron in 20-day-old pigs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tail docking using clippers or cautery iron in 2-day-old pigs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tail docking in 2-day-old pigs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tail docking in 20-day-old pigs
Number of subjects: 40
Study: 26321155

Group type: EXPERIMENTAL
Intervention: P10 (chemical-cured resin composite)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: P30 (light-cured resin composite)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Miradapt (chemical-cured resin composite)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 30
Study: 23442174

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced ultrasonography (CEUS) during LRFA
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no CEUS)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 96
Study: 21204871

Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus NCFM
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis Bi-07
Number of subjects: 50

Group type: COMPARATOR
Intervention: Probiotic intake
Number of subjects: 50
Study: 19650825

Group type: EXPERIMENTAL
Intervention: AZD9343 320 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Baclofen 40 mg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 17239705

Group type: EXPERIMENTAL
Intervention: Istaroxime at doses >or=1 micro/kg per min
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Istaroxime at doses of 0.5 micro/kg per min
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Istaroxime
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Istaroxime up to 3.33 micro/kg per min
Number of subjects: 18
Study: 15078001

Group type: EXPERIMENTAL
Intervention: Ertapenem 1 g daily
Number of subjects: 236

Group type: COMPARATOR
Intervention: Piperacillin-tazobactam 3.375 g every 6 h
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Complicated appendicitis
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 236
Study: 14642996

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) at a mean dose of 2053 mg/day for a duration of 125 days
Number of subjects: 970

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 970
Study: 10451131

Group type: EXPERIMENTAL
Intervention: 100 mg tramadol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 200 mg tramadol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (Control group)
Number of subjects: 60
Study: 7851201

Group type: EXPERIMENTAL
Intervention: Bran (20 g/24 hr)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2108510

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate
Number of subjects: 28

Group type: COMPARATOR
Intervention: Oxygen therapy alone
Number of subjects: 28
Study: 7465712

Group type: EXPERIMENTAL
Intervention: Contingent Feedback
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Feedback plus Exteroceptive Cues
Number of subjects: 18

Group type: COMPARATOR
Intervention: Random Feedback Control
Number of subjects: 18
Study: 31465818

Group type: EXPERIMENTAL
Intervention: Resin infiltration + flossing (test group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Flossing (control group)
Number of subjects: 50
Study: 27567635

Group type: EXPERIMENTAL
Intervention: NOVOCART® Disk plus (autologous disk chondrocyte transplantation)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Carrier material only (control)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: NOVOCART® Disk plus
Number of subjects: 24
Study: 25437877

Group type: EXPERIMENTAL
Intervention: 6-month semi-supervised moderate exercise protocol (EX, n = 66)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Health education control (CON, n = 62)
Number of subjects: 128
Study: 23497557

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oxygen mask (OM)
Number of subjects: 40
Study: 22131599

Group type: EXPERIMENTAL
Intervention: Exercise training (n = 27)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Stretching control (n = 16)
Number of subjects: 43